| Bhavish Shah, MD | |
|
85 Spring St, Laconia, NH 03246-3113 | |
| (603) 527-2970 | |
| (603) 527-2874 |
| Full Name | Bhavish Shah |
|---|---|
| Gender | Male |
| Speciality | |
| Experience | Years |
| Location | 85 Spring St, Laconia, New Hampshire |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1811190887 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | 4301078234 (Michigan) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Bhavish Shah, MD Po Box 1327, Laconia, NH 03247-1327 Ph: (603) 524-3211 | Bhavish Shah, MD 85 Spring St, Laconia, NH 03246-3113 Ph: (603) 527-2970 |
News Archive
Exelixis, Inc. today announced that the U.S. Food & Drug Administration (FDA) has granted orphan drug designation to XL184 for treatment of follicular, medullary, and anaplastic thyroid carcinoma, and metastatic or locally advanced papillary thyroid cancer. A pivotal phase 3 trial of XL184 is ongoing in patients with medullary thyroid cancer (MTC) and the company expects to release top-line phase 3 results in the first-half of 2011 and potentially file a New Drug Application (NDA) for the compound in the second-half of 2011.
Legend has it that Ralph Waldo Emerson once said, "Build a better mousetrap, and the world will beat a path to your door." University of Missouri researchers are doing just that, but instead of building mousetraps, the scientists are targeting cancer drugs. In a new study, MU medicinal chemists have taken an existing drug that is being developed for use in fighting certain types of cancer, added a special structure to it, and created a more potent, efficient weapon against cancer.
A study led by researchers in the Department of Neurosciences at the University of California, San Diego School of Medicine shows unexpected and extensive natural recovery after spinal cord injury in primates. The findings, to be published November 14 in the advance online edition of Nature Neuroscience, may one day lead to the development of new treatments for patients with spinal cord injuries.
United Health's CEO Stephen Hemsley said he expects companies to keep offering benefits instead of pushing people to health exchanges created in 2014 by the federal government, Bloomberg Businessweek reports.
› Verified 5 days ago
Nino Idoidze, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 80 Highland St, Laconia, NH 03246 Phone: 603-524-3211 | |
Farkhat Galiullin, Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 80 Highland St, Laconia, NH 03246 Phone: 603-524-3211 Fax: 603-737-6713 | |
Dr. Mary-claire Sampas Paicopolis, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 85 Spring St, Laconia, NH 03246 Phone: 603-528-8555 Fax: 603-528-7668 | |
Noshi A Ishak, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 87 Spring Street, Laconia, NH 03246 Phone: 603-524-8896 Fax: 603-524-8796 | |
Gurpinder Singh, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 80 Highland Street, Laconia, NH 03246 Phone: 603-524-3211 Fax: 603-737-6713 | |
Shamai Kurbitaeva, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 80 Highland St, Laconia, NH 03246 Phone: 347-844-2314 | |
Sharan Sharma, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 80 Highland St, Laconia, NH 03246 Phone: 603-524-3211 Fax: 603-737-6713 |